These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17824503)

  • 21. The seven deadly sins of business development.
    Stewart JJ; Bonifant B
    Nat Biotechnol; 2008 Apr; 26(4):375-7. PubMed ID: 18404814
    [No Abstract]   [Full Text] [Related]  

  • 22. Data-miners vow to fight bans. Groups claim marketing used to improve quality.
    Blesch G
    Mod Healthc; 2009 Jul; 39(27):15. PubMed ID: 19606667
    [No Abstract]   [Full Text] [Related]  

  • 23. PhRMA speaks! And we all listen.
    Huff B
    GMHC Treat Issues; 2002 Apr; 16(4):10-1. PubMed ID: 12141257
    [No Abstract]   [Full Text] [Related]  

  • 24. Appetite for cheaper biologics spreads across the map.
    Senior M
    Nat Biotechnol; 2013 Dec; 31(12):1059-61. PubMed ID: 24316622
    [No Abstract]   [Full Text] [Related]  

  • 25. Bob Franks. President, HealthCare Institute of New Jersey.
    Franks B
    N J Med; 2002; 99(1-2):14-20. PubMed ID: 15211889
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharma swept up in biogenerics gold rush.
    Ratner M
    Nat Biotechnol; 2009 Apr; 27(4):299-301. PubMed ID: 19352348
    [No Abstract]   [Full Text] [Related]  

  • 27. Biocon's first-in-class anti-CD6 mAb reaches the market.
    Jayaraman K
    Nat Biotechnol; 2013 Dec; 31(12):1062-3. PubMed ID: 24316625
    [No Abstract]   [Full Text] [Related]  

  • 28. Academy for Health Services Marketing.
    J Health Care Mark; 1981; 1(3):55-6. PubMed ID: 10252810
    [No Abstract]   [Full Text] [Related]  

  • 29. American Marketing Association launches new healthcare council.
    Jaklevic MC
    Mod Healthc; 1994 Oct; 24(42):14, 16. PubMed ID: 10137232
    [No Abstract]   [Full Text] [Related]  

  • 30. Promote ASE, and let its resources help you!
    Frommelt P
    J Am Soc Echocardiogr; 2009 Jun; 22(6):A28. PubMed ID: 19501323
    [No Abstract]   [Full Text] [Related]  

  • 31. Challenges in realizing the potential of clinical molecular imaging.
    Lusser M
    J Nucl Med; 2008 Jun; 49(6):72N-73N. PubMed ID: 18511835
    [No Abstract]   [Full Text] [Related]  

  • 32. How to commercialize nanotechnology.
    Helmus MN
    Nat Nanotechnol; 2006 Dec; 1(3):157-8. PubMed ID: 18654171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
    Kale SA; Barkin RL
    Compr Ther; 2009; 35(2):68-71. PubMed ID: 19618754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-mind and open-door.
    Apple WS
    J Am Pharm Assoc; 1967 Jun; 7(6):294-6. PubMed ID: 6045619
    [No Abstract]   [Full Text] [Related]  

  • 35. Nurse Practitioner Corporate Partner Council.
    Dempster JS
    J Am Acad Nurse Pract; 2007 Dec; 19(12):676-7. PubMed ID: 18042133
    [No Abstract]   [Full Text] [Related]  

  • 36. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

  • 37. A marketing magic bullet?
    Rooney H
    Caring; 2006 Sep; 25(9):32-4, 36-7. PubMed ID: 17022321
    [No Abstract]   [Full Text] [Related]  

  • 38. Developing a marketing strategy.
    Tarantino D
    Physician Exec; 2003; 29(1):54-5. PubMed ID: 12555731
    [No Abstract]   [Full Text] [Related]  

  • 39. Respiratory drug market dynamics.
    Oversteegen L; Rovini H; Belsey MJ
    Nat Rev Drug Discov; 2007 Sep; 6(9):695-6. PubMed ID: 17907343
    [No Abstract]   [Full Text] [Related]  

  • 40. Making the case for molecular imaging.
    Schick M
    J Nucl Med; 2008 Jun; 49(6):75N-77N. PubMed ID: 18511837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.